Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

KaloBios Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 Feb 2016 Reuters Investment Profile 12 $20.00

Trading Report for (KBIO). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for KBIO. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

05 Feb 2016 Stock Traders Daily 6 $20.00

ValuEngine Rating and Forecast Report for KBIOQ

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

31 Jan 2016 ValuEngine, Inc. 11 $25.00

Value Graph: KALOBIOS PHARMA -- KBIOQ

29 Jan 2016 Ford Investor Services, Inc. 1 $12.00

ValuEngine Rating and Forecast Report for KBIO

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

10 Jan 2016 ValuEngine, Inc. 11 $25.00

Thomson Reuters Stock Report - KaloBios Pharmaceuticals Inc (KBIO-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

25 Dec 2015 Thomson Reuters Stock Report 10 $25.00

Wright Investors Service Comprehensive Report for Kalobios Pharmaceuticals Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

25 Dec 2015 Wright Reports 55 $75.00

KaloBios Pharmaceuticals, Inc. (KBIO) - Financial Analysis Review

KaloBios Pharmaceuticals, Inc. (KBIO) - Financial Analysis Review Summary KaloBios Pharmaceuticals, Inc. (KaloBios) is a biop...

11 Dec 2015 GlobalData 47 $300.00

KaloBios Pharmaceuticals, Inc. (KBIO) - Financial Analysis Review

KaloBios Pharmaceuticals, Inc. (KBIO) - Financial Analysis Review Summary KaloBios Pharmaceuticals, Inc. (KaloBios) is ...

21 Sep 2015 GlobalData 37 $125.00

ValuEngine Industry Report for Medical-Generic Drugs(KBIO)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

20 Aug 2015 ValuEngine, Inc. 10 $49.00